Adedigbo A. Fasanmade

Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure

Eugene S. Chung, Milton Packer, Kim Hung Lo et al. · Circulation · 2003 · 1.6K citations

Pharmacy, Cardiology, Pharmacotherapy +12

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double‐blind, placebo‐controlled trial

E. William St. Clair, Carrie Wagner, Adedigbo A. Fasanmade et al. · Arthritis & Rheumatism · 2002 · 423 citations

Medicine, Pharmacology, Pharmacotherapy +13

A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

Nicolino Ruperto, Daniel J. Lovell, Rubén Cuttica et al. · Arthritis & Rheumatism · 2007 · 411 citations

Medicine, Pediatrics, Pharmacotherapy +12

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis

Adedigbo A. Fasanmade, Omoniyi J. Adedokun, Joyce Ford et al. · European Journal of Clinical Pharmacology · 2009 · 321 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14

Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials

Adedigbo A. Fasanmade, Omoniyi J. Adedokun, Marion Blank et al. · Clinical Therapeutics · 2011 · 289 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16